Scopolamine intranasal - Repurposed /NASA

Drug Profile

Scopolamine intranasal - Repurposed /NASA

Alternative Names: INSCOP spray

Latest Information Update: 01 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Epiomed Therapeutics
  • Developer Repurposed Therapeutics
  • Class Antiemetics; Antispasmodics; Hypnosedatives; Mydriatics; Tropanes
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Motion sickness

Most Recent Events

  • 01 Jun 2014 Phase-II/III clinical trials in Motion sickness in USA (Intranasal)
  • 12 Oct 2012 Clinical trials in Motion sickness in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top